Treatment with antidepressants in the Swedish population in relation to major workplace downsizingShow others and affiliations
2014 (English)In: 17th EPA Section Meeting 2014: Abstracts, 2014, p. 75-75Conference paper, Oral presentation with published abstract (Refereed)
Abstract [en]
Background/Objectives: Previous research has indicated that downsizing may be a risk factor for morbidity and mortality both among those who are made redundant and those remaining in the workplace. However, there are contradictory results and little evidence on clinically relevant mental health effects. Our objective was to investigate change in antidepressants treatment across 5 years in relation to workplace downsizing.
Methods: This study is based on all individuals in Sweden 22-54 years of age in 2006, registered as living in Sweden Dec 31 2004 to Dec 31 2010, gainfully employed and with a stable labour market position in 2004-2006. Organisational changes were assessed from national statistics on workplaces and purchases of prescribed psychotropic drugs from the Prescribed Drug Register. People with their primary employment at an establishment with ≥ 18 % personnel reduction were considered exposed to major downsizing between the end of 2006 to the end of 2007, 2007-2008 or 2008- 2009. We applied a repeated-measures regression analysis by the generalised estimating equations (GEE) method, calculating yearly prevalence of any antidepressant treatment two years before, during the year of major downsizing and two years after workplace downsizing and tested for trends.
Results: There was a significant increase in prevalence of antidepressant treatment during the years preceding a major downsizing, although small, for all exposed (632500 persons). In separate analyses, however, only those who remained at the same establishment at the end of the downsizing period (stayers) had a significant upward trend before and a downward trend in the years after, and this was most obvious among survivors with no long period of sickness absence or disability pension the past two year before downsizing. The prevalence ratio (PR) comparing year -1 to -2 was 1.11 with 95 % confidence interval (CI) of 1.10-1.13 and the PR comparing year 2 to 1 after was 0.98 (CI 0.96-1.00, P<0.05). Among those becoming unemployed, the prevalence of antidepressant treatment tended to increase before but then stayed virtually the same during and after downsizing. The patterns were slightly different for people with longer periods of sickness absence or disability pension before, especially for those changing jobs, but a significant decrease in prevalence was only found when analysing stayers, job changers and unemployed collectively (PR 0.83, CI 0.77-0.88).
Discussion/Conclusions: This large scale study indicates that downsizing is associated with increased risk of treatment with antidepressants among those seemingly healthy before and remaining in work after major personnel reduction. Moreover, the increased prevalence for those remaining at the same workplace seems to be explained by workplace characteristics or anticipation some time before downsizing was carried out.
Funding: The study was supported by the Swedish Research Council for Health, Working Life and Welfare (FORTE) [grant numbers 2009-1758, 2008-1103], partly through the Stockholm Stress Centre of excellence.
Place, publisher, year, edition, pages
2014. p. 75-75
Keywords [en]
Downsizing, organisational change, depressive disorder, antidepressants
National Category
Public Health, Global Health and Social Medicine
Identifiers
URN: urn:nbn:se:su:diva-109649Local ID: P-3193OAI: oai:DiVA.org:su-109649DiVA, id: diva2:766202
Conference
17th EPA Section Epidemiology and Social Psychiatry Meeting, Ulm, Germany, May 21–24, 2014
2014-11-262014-11-262025-02-20Bibliographically approved